StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories long-Lived Assets — United States ($M) ($M)

Postgres DB segment_values + Form 10-K Geographic Footnote

QuarterlyAnnual
Latest, Q4 2025
11,900
Period ended Dec 31, 2025
Change on a year earlier
+15.5%
10,300 in Q4 2024
History
12 quarters
Since Q4 2014
Sources
11
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLong-Lived Assets — United States ($M) ($M)Year on yearSource
Q4 2025Dec 31, 202511,900+15.5%Form 10-K (filed 2026-02-20) ↗
Q4 2024Dec 31, 202410,300+15.7%Form 10-K (filed 2025-02-21) ↗
Q4 2023Dec 31, 20238,900+15.6%Form 10-K (filed 2024-02-16) ↗
Q4 2022Dec 31, 20227,700+13.2%Form 10-K (filed 2023-02-17) ↗
Q4 2021Dec 31, 20216,800+11.5%Form 10-K (filed 2022-02-18) ↗
Q4 2020Dec 31, 20206,100+19.6%Form 10-K (filed 2021-02-19) ↗
Q4 2019Dec 31, 20195,100+18.6%Form 10-K (filed 2020-02-21) ↗
Q4 2018Dec 31, 20184,300-4.4%Form 10-K (filed 2019-02-22) ↗
Q4 2017Dec 31, 20174,500+45.2%Form 10-K (filed 2018-02-16) ↗
Q4 2016Dec 31, 20163,1000.0%Form 10-K (filed 2017-02-17) ↗
Q4 2015Dec 31, 20153,1000.0%Form 10-K (filed 2016-02-19) ↗
Q4 2014Dec 31, 20143,100–Form 10-K (filed 2016-02-19) ↗

Cite this data

StockData. (2026). Abbott Laboratories Long-Lived Assets — United States ($M) ($M), quarterly Q4 2014–Q4 2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-lla-us

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.